General Information of Drug (ID: DR1770)
Drug Name
Hydroxyamphetamine
Synonyms
Hydroxyamfetamine; Hydroxyamphetamide; Norpholedrine; Norveritol; Nov-Pholedrin; Oksamfetamin; Oxamfetamin; Oxamphetamine; Oxamphetaminium; Paradrine; Paredrine; Paredrinex; Pedrolon; Phenol, 4-(2-aminopropyl)-; Phenol, p-(2-aminopropyl)-; Phenol,4-(2-aminopropyl)-; Pulsoton; alpha-Methyltyramine; hydroxyamphetamine; p-(2-Aminopropyl)phenol; p-HYDROXYAMPHETAMINE; .alpha.-Methyltyramine; 1-p-Hydroxyphenyl-2-propylamine; 103-86-6; 2-Amino-1-(p-hydroxyphenyl)propane; 4-(2-Aminopropyl)phenol; 4-Hydroxyamphetamine
Indication Horner syndrome [ICD11: 8D8A] Approved [1]
Structure
3D MOL 2D MOL
Pharmaceutical Properties Molecular Weight 151.21 Topological Polar Surface Area 46.2
Heavy Atom Count 11 Rotatable Bond Count 2
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 2
Cross-matching ID
PubChem CID
3651
ChEBI ID
CHEBI:103855
CAS Number
103-86-6
Formula
C9H13NO
Canonical SMILES
CC(CC1=CC=C(C=C1)O)N
InChI
1S/C9H13NO/c1-7(10)6-8-2-4-9(11)5-3-8/h2-5,7,11H,6,10H2,1H3
InChIKey
GIKNHHRFLCDOEU-UHFFFAOYSA-N
The Metabolic Roadmap of This Drug
The Full List of Drug Metabolites (DM) of This Drug
DM Name DM ID PubChem ID Reaction DM Level REF
Hydroxynorephedrine DM004779 N. A. Oxidation - Beta-hydroxylation 1 [3]
The Full List of Metabolic Reaction (MR) of This Drug
MR ID Reactant Product MR Type DME REF
MR005139 Hydroxyamphetamine Hydroxynorephedrine Oxidation - Beta-hydroxylation DOB [3]
Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug
DME Name DME Info Species Uniprot ID EC Number REF
Cytochrome P450 3A4 (CYP3A4) DME0001 Homo sapiens
CP3A4_HUMAN
1.14.14.55
[2]
dopamine-beta-oxidase (DOB) DMEN244 Homo sapiens Not Available Not Available [3]
References
1 Hydroxyamphetamine was approved by FDA. The 2020 official website of the U.S. Food and Drug Administration.
2 Stereoselective method development and validation for determination of concentrations of amphetamine-type stimulants and metabolites in human urine using a simultaneous extraction-chiral derivatization approach. J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Jan 1;879(1):8-16.
3 Dopamine-beta-oxidase activity in man, using hydroxyamphetamine as substrate

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.